CytomX Therapeutics Statistics
NASDAQ: CTMXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.03-0.02 (-0.98%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
CytomX Therapeutics by the numbers
CytomX Therapeutics has a market capitalization of $442.5 million based on 218.00M shares outstanding. With trailing EPS of $-0.51, CytomX Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 15.8% below its 50-day average and 43.8% below its 200-day average.
Average daily trading volume is 4.27M shares, or about $8.7 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CTMX valuation vs. peer median
| Metric | CTMX | Peer median | Difference |
|---|---|---|---|
| Market cap | $442.55M | $446.00M | -1% |
| Avg. volume | 4.27M | 259.12K | +1547% |
Peer median across 8 companies: KMDA, DMAC, AMRN, LYEL, CAPR, STTK, ASMB, NGNE.
Valuation
- Market cap
- $442.55M
- Price / sales (latest FY)
- 5.81
- EPS (TTM)
- $-0.51
- Shares outstanding
- 218.00M
Price and trading
- Previous close
- 2.05
- Open
- 2.02
- Day range
- 1.97 – 2.16
- 52-week range
- 1.87 – 8.21
- 52-week change
- -47.68%
- Beta
- —
- Volume
- 4.87M
- Average volume
- 4.27M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 442.55M
- Forward Pe
- -4.07
- Eps
- -0.51
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 8.21
- Week52 Low
- 1.87
- Avg Volume
- 4.27M
- Shares Outstanding
- 218.00M
- Ma50
- 2.41
- Ma200
- 3.61
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -75.27%
- Pct From52w Low
- 8.56%